Altium Capital Management LP Harmony Biosciences Holdings, Inc. Transaction History

Altium Capital Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$31.89 - $39.03 $1.05 Million - $1.28 Million	-32,889 Reduced 21.94%	117,000 $3.83 Million
Q2 2023 Aug 14, 2023	BUY	$30.5 - $37.4 $3.66 Million - $4.48 Million	119,889 Added 399.63%	149,889 $5.27 Million
Q1 2023 May 15, 2023	BUY	$30.8 - $53.92 $924,000 - $1.62 Million	30,000 New	30,000 $979,000
Q2 2022 Aug 15, 2022	BUY	$33.54 - $52.15 $1.68 Million - $2.61 Million	50,000 New	50,000 $2.44 Million

243

45.2M

108K

49.2K

Ticker HRMY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,161,400
Market Cap $2.04B
Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...

Get notified when there are updates to the investment portfolio of Altium Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Altium Capital Management LP with notifications on news.